Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …

Stem cell therapy has been used to treat several types of diseases, and it is expected that its
therapeutic uses shall increase as novel lines of evidence begin to appear. Furthermore …

Time-released delivery of soluble growth factors (GFs) in engineered hydrogel tissue
constructs promotes the migration and proliferation of embedded cells, which is an important …

Dysfunction of basal forebrain cholinergic neurons (BFCNs) and γ-aminobutyric acid (GABA)
interneurons, derived from medial ganglionic eminence (MGE), is implicated in disorders of …

Neuronal loss is a major pathological outcome of many common neurological disorders,
including ischemia, traumatic brain injury, and Alzheimer disease. Stem cell-based …

Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by
progressive and irreversible decline of memory. Neuropathological features include the …

Amyotrophic lateral sclerosis (ALS) is a late-onset progressive degeneration of motor
neurons occurring both as a sporadic and a familial disease. The etiology of ALS remains …

Alzheimer's disease (AD) as a dementia and neurodegenerative disease, is mostly
prevalent among people more than 65 years. AD is mostly manifested in the form of …

Cell therapy is thought to have a central role in restorative therapy, which aims to restore the
function of the damaged nervous system. Neural stem cells (NSCs) can differentiate into …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease and a worldwide
health challenge. Different therapeutic approaches are being developed to reverse or slow …